PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Total Debt | ₹4,559 Cr | ₹5,505 Cr | ₹4,023 Cr | ₹2,910 Cr |
What is the latest Total Debt ratio of PIRAMAL PHARMA ?
Year | Total Debt |
---|---|
Mar2024 | ₹4,559 Cr |
Mar2023 | ₹5,505 Cr |
Mar2022 | ₹4,023 Cr |
Mar2021 | ₹2,910 Cr |
How is Total Debt of PIRAMAL PHARMA Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹4,559 Cr | -17.18 | |
Mar2023 | ₹5,505 Cr | 36.82 | |
Mar2022 | ₹4,023 Cr | 38.25 | |
Mar2021 | ₹2,910 Cr | - |
Compare Total Debt of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹31,783.7 Cr | 3.9% | -6.1% | 69% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 3.9% |
-6.1% |
69% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses